These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1085153)

  • 1. [Effects of apomorphine on the vestibulo-ocular reflex in normal subjects and in patients with parkinsonism].
    Serlenga L; Genco S; Puca FM; Specchio LM; Brignone A
    Boll Soc Ital Biol Sper; 1975 Oct; 51(20):1382-6. PubMed ID: 1085153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of dopamine on the vestibulo-ocular reflex in parkinsonism].
    Genco S; Puca FM; Serlenga L; Brignone A; Specchio LM
    Boll Soc Ital Biol Sper; 1975 Oct; 51(20):1375-81. PubMed ID: 1085152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modifications induced by antidepressant drugs on the vestibulo-ocular reflex in man].
    Specchio LM; Brignone A; Puca FM; Genco S; Serlenga L
    Boll Soc Ital Biol Sper; 1975 Oct; 51(20):1369-74. PubMed ID: 1085151
    [No Abstract]   [Full Text] [Related]  

  • 4. [Positioning reflex and eye movements induced by diffuse illumination].
    Arduini A; Arduini MT
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1794-7. PubMed ID: 1231857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine].
    Merello M; Leiguarda R
    Medicina (B Aires); 1995; 55(1):5-10. PubMed ID: 7565037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ; Obering C
    Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral pharmacokinetics of apomorphine in humans.
    Gancher ST; Woodward WR; Boucher B; Nutt JG
    Ann Neurol; 1989 Aug; 26(2):232-8. PubMed ID: 2774511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apomorphine for treatment of "off-periods" in Parkinson's disease].
    Zoldan J; Merims D; Kuritzky A; Ziv I; Melamed E
    Harefuah; 1999 Nov; 137(10):444-6, 512, 511. PubMed ID: 10959339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apomorphine].
    Esteban Muñoz J
    Neurologia; 1995 Oct; 10(8):330-7. PubMed ID: 8554783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Subcutaneous apomorphine infusion in the treatment of Parkinson disease].
    Albani C; Zangger I; Fischer G
    Schweiz Rundsch Med Prax; 1992 Aug; 81(35):1011-5. PubMed ID: 1410978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease].
    Pollak P; Champay AS; Gaio JM; Hommel M; Benabid AL; Perret J
    Rev Neurol (Paris); 1990; 146(2):116-22. PubMed ID: 2320817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of vestibulo-ocular reflexes in congenital nystagmus.
    Gresty MA; Barratt HJ; Page NG; Ell JJ
    Ann Neurol; 1985 Feb; 17(2):129-36. PubMed ID: 3872095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of apomorphine on flexor reflex and periodic limb movement.
    Paradiso G; Khan F; Chen R
    Mov Disord; 2002 May; 17(3):594-7. PubMed ID: 12112213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subcutaneous apomorphine--a valuable therapeutic alternative in Parkinson disease].
    Odin P; Mangalanayagam L; Nilsson B; Lindvall O
    Lakartidningen; 1991 Nov; 88(45):3811-4. PubMed ID: 1943399
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease.
    Wenning GK; Bösch S; Luginger E; Wagner M; Poewe W
    Adv Neurol; 1999; 80():545-8. PubMed ID: 10410769
    [No Abstract]   [Full Text] [Related]  

  • 16. [Subcutaneous apomorphine in the treatment of Parkinson's disease].
    Linazasoro G
    Neurologia; 1994 Jan; 9(1):1-3. PubMed ID: 8161461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ['New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine].
    Jansen EN; van Laar T
    Ned Tijdschr Geneeskd; 1990 May; 134(18):889-91. PubMed ID: 2345577
    [No Abstract]   [Full Text] [Related]  

  • 18. A mathematical model of the vestibulo-oculomotor reflex in physiological and pathological conditions.
    Montella R; Ghilardi PL; Guglielmino S; Giampietro C
    Acta Otolaryngol Suppl; 1977; 346():1-18. PubMed ID: 305184
    [No Abstract]   [Full Text] [Related]  

  • 19. Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease.
    LeWitt PA; Ondo WG; Van Lunen B; Bottini PB
    Clin Neuropharmacol; 2009; 32(2):89-93. PubMed ID: 18978491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subcutaneous apomorphine in major motor oscillations of parkinsonian patients].
    Petit H; Vermersch P; Caparros-Lefebvre D
    Presse Med; 1992 Feb; 21(4):172. PubMed ID: 1532076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.